1. Home
  2. PM vs NVO Comparison

PM vs NVO Comparison

Compare PM & NVO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • PM
  • NVO
  • Stock Information
  • Founded
  • PM 1987
  • NVO 1923
  • Country
  • PM United States
  • NVO Denmark
  • Employees
  • PM N/A
  • NVO N/A
  • Industry
  • PM Medicinal Chemicals and Botanical Products
  • NVO Biotechnology: Biological Products (No Diagnostic Substances)
  • Sector
  • PM Health Care
  • NVO Health Care
  • Exchange
  • PM Nasdaq
  • NVO Nasdaq
  • Market Cap
  • PM 283.9B
  • NVO 278.0B
  • IPO Year
  • PM N/A
  • NVO N/A
  • Fundamental
  • Price
  • PM $162.92
  • NVO $48.17
  • Analyst Decision
  • PM Strong Buy
  • NVO Buy
  • Analyst Count
  • PM 12
  • NVO 5
  • Target Price
  • PM $179.50
  • NVO $112.00
  • AVG Volume (30 Days)
  • PM 6.9M
  • NVO 19.3M
  • Earning Date
  • PM 07-22-2025
  • NVO 08-11-2025
  • Dividend Yield
  • PM 3.31%
  • NVO 2.45%
  • EPS Growth
  • PM N/A
  • NVO 17.93
  • EPS
  • PM 5.27
  • NVO 3.40
  • Revenue
  • PM $39,058,000,000.00
  • NVO $43,922,211,349.00
  • Revenue This Year
  • PM $11.61
  • NVO $13.92
  • Revenue Next Year
  • PM $8.43
  • NVO $14.04
  • P/E Ratio
  • PM $30.91
  • NVO $14.17
  • Revenue Growth
  • PM 7.16
  • NVO 24.11
  • 52 Week Low
  • PM $113.15
  • NVO $46.90
  • 52 Week High
  • PM $186.69
  • NVO $139.74
  • Technical
  • Relative Strength Index (RSI)
  • PM 36.49
  • NVO 23.96
  • Support Level
  • PM $161.07
  • NVO $46.90
  • Resistance Level
  • PM $181.31
  • NVO $71.80
  • Average True Range (ATR)
  • PM 4.08
  • NVO 1.71
  • MACD
  • PM -1.13
  • NVO -2.26
  • Stochastic Oscillator
  • PM 25.52
  • NVO 5.10

About PM Philip Morris International Inc

Created from the international operations of Altria in 2008, Philip Morris International sells cigarettes and reduced-risk products, including heatsticks, vapes, and oral nicotine offerings primarily outside of the US. With the 2023 acquisition of Swedish Match, a leading manufacturer of traditional oral tobacco products and nicotine pouches primarily in the US and Scandinavia, PMI has not only diversified away from smokeable products but also gained a toehold into the US to sell its iQOS heated tobacco product.

About NVO Novo Nordisk A/S

With roughly one third of the global branded diabetes treatment market, Novo Nordisk is the leading provider of diabetes-care products in the world. Based in Denmark, the company manufactures and markets a variety of human and modern insulins, injectable diabetes treatments such as GLP-1 therapy, oral antidiabetic agents, and obesity treatments. Novo also has a biopharmaceutical segment (constituting less than 10% of revenue) that specializes in protein therapies for hemophilia and other disorders.

Share on Social Networks: